ArticlemAbs2014

Generation of novel monoclonal antibodies for the enrichment and characterization of human corneal endothelial cells (hCENC) necessary for the treatment of corneal endothelial blindness.

Vanessa Ding et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.